Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02206802 · ClinicalTrials.gov registry record
Minoxidil Response Testing in Females With Female Pattern Hair Loss
A clinical trial of Alopecia and Female Pattern Hair Loss, sponsored by Applied Biology.
- Completed
- Registry status
- 300
- Enrollment target
- 5
- Study locations
NCT02206802: Completed study of Alopecia and Female Pattern Hair Loss, sponsored by Applied Biology.
NCT02206802 is a study of Alopecia and Female Pattern Hair Loss that has completed, run by Applied Biology. The registered enrollment target is 300 participants, above the 102-participant average among 13 other Alopecia trials with a reported enrollment target (194% higher). The trial reports 5 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02206802, a study of Alopecia and Female Pattern Hair Loss, has completed, sponsored by Applied Biology.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
- 5
- Study locations
Study Summary
The primary purpose of this study is to evaluate the clinical validity of the minoxidil response in-vitro diagnostic kit.
Primary Outcome
Number of hairs measured in the target area by macrophotography.
Conditions Studied
Interventions
- DRUG 5% minoxidil topical foam
Study Locations (5)
Other
- Sinclair Dermatology - East Melbourne
- LTM Medical College & Hospital - Mumbai
- Istituto Medico Tricologico/Studi Life Cronos - Florence
Arizona
- Physicians Hair Institute - Tucson
Tennessee
- Tennessee Clinical Research Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2014-07 |
| Est. Completion | 2018-10 |
What the finished NCT02206802 record still lists
NCT02206802 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 102-participant average among 13 other Alopecia trials with a reported enrollment target (194% higher).
The record links to 2 conditions, with Alopecia appearing as the primary indexed condition, and to 1 intervention - of which 5% minoxidil topical foam is the first listed.
NCT02206802 lists 5 locations in 3 states (Other, Arizona, Tennessee).
Frequently Asked Questions
What is clinical trial NCT02206802 about?
NCT02206802 is a clinical study titled "Minoxidil Response Testing in Females With Female Pattern Hair Loss". The primary purpose of this study is to evaluate the clinical validity of the minoxidil response in-vitro diagnostic kit.
What is the current status of trial NCT02206802?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2014-07. Estimated completion is 2018-10.
What conditions does trial NCT02206802 study?
This clinical trial studies the following conditions: Alopecia, Female Pattern Hair Loss.
What interventions are being tested in trial NCT02206802?
The interventions under investigation include: 5% minoxidil topical foam (DRUG).
Who is sponsoring clinical trial NCT02206802?
This trial is sponsored by Applied Biology, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02206802 being conducted?
This trial has 5 study locations across Arizona, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alopecia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02206802's enrollment target sits among peer trials
300 2nd of 13 the highest of 13 other Alopecia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alopecia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)
RECRUITING · NA
-
Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors
RECRUITING · NA
-
Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
RECRUITING · NA
-
Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color
RECRUITING · NA
-
Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands Region
RECRUITING · NA
-
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia